Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.92
Delayed Data
As of Jun 29
 -0.06 / -3.03%
Today’s Change
1.53
Today|||52-Week Range
3.78
+4.35%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close1.98
Today’s open1.95
Day’s range1.88 - 1.97
Volume204,010
Average volume (3 months)373,286
Market cap$185.3M
Dividend yield--
Data as of 4:02pm ET, 06/29/2015

Growth & Valuation

Earnings growth (last year)-6.67%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.68%
P/E ratioNM
Price/Sales11.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PSTIPluristem Therapeuti...-0.07-2.73%
CURNeuralstem Inc-0.24-11.88%
FATEFate Therapeutics In...-0.23-3.65%
ENZYEnzymotec Ltd-0.52-5.78%
Data as of 4:00pm ET, 06/29/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$15.2M
Annual profit (last year)-$29.9M
Net profit margin-197.51%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers